Processa Pharmaceuticals, Inc. Research And Development Expense

Quick Answer

Processa Pharmaceuticals, Inc. reported Research And Development Expense of $3.17 million for the year ending 2020.

  • Processa Pharmaceuticals, Inc. showed an increase of +36.7% in Research And Development Expense from 2019 to 2020.
  • This data is from Processa Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2021.
  • XBRL data for this metric is available from 2012 to 2020 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2012 to 2020), Processa Pharmaceuticals, Inc.'s Research And Development Expense has grown by 608.1%.
  • Historical annual values: Fiscal year 2020: $3.17 million | Fiscal year 2019: $2.32 million | Fiscal year 2018: $3.09 million | Fiscal year 2017: $964.2 thousand | Fiscal year 2016: $6.6 thousand | Fiscal year 2015: $29.2 thousand | Fiscal year 2014: $178.1 thousand | Fiscal year 2013: $267.1 thousand | Fiscal year 2012: $448.0 thousand.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: